Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...

Around 220,000 Brits are expected to receive Mounjaro through the NHS over the next three years – but what are the side ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...

Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

The mass rollout of the drugs on the NHS in England will begin on Monday (June 23) as GPs are allowed to prescribe weight ...

Drugs in the same family as Ozempic and Wegovy are known for treating diabetes and helping with weight loss, but a small, ...

The mass rollout of weight loss jabs on the NHS in England will begin on Monday as GPs are allowed to prescribe the drugs for ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...